for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-MEI pharma's pracinostat receives FDA's breakthrough therapy designation

Aug 1 (Reuters) - MEI Pharma Inc :

* MEI Pharma’s pracinostat receives breakthrough therapy designation from FDA for treatment in combination with azacitidine of patients with newly diagnosed acute myeloid leukemia unfit for intensive chemotherapy

* Agreement has been reached with FDA on company’s proposed phase III study design Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up